<?xml version="1.0" encoding="UTF-8"?>
<p>Taking into account the above-mentioned results (scenario 1), the incremental direct costs would have been €11.7 million (payer perspective) and €6.5 million from societal perspective (discounted savings per year). In terms of health-related outcomes, a total of 4,286 QALYs would have been saved per year. This results in an ICER of €2,751 per QALY gained from a payer perspective and €1,527 from a societal perspective. These results were robust as shown in 
 <xref ref-type="fig" rid="pone.0233526.g003">Fig 3</xref> for the deterministic sensitivity analysis and in 
 <xref rid="pone.0233526.t005" ref-type="table">Table 5</xref> for the PSA.
</p>
